STRS OHIO - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 145 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
STRS OHIO ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2022$504,000
-22.5%
36,200
-23.1%
0.00%
-33.3%
Q2 2022$650,000
+44.4%
47,100
+70.0%
0.00%
+50.0%
Q1 2022$450,000
-45.9%
27,700
-45.8%
0.00%
-33.3%
Q4 2021$832,000
+9.8%
51,1000.0%0.00%0.0%
Q3 2021$758,000
+143.7%
51,100
+227.6%
0.00%
+200.0%
Q2 2021$311,000
+498.1%
15,600
+1318.2%
0.00%
Q2 2020$52,000
+766.7%
1,100
+1000.0%
0.00%
Q1 2020$6,000
-97.6%
100
-95.0%
0.00%
-100.0%
Q4 2019$247,000
+177.5%
2,000
+150.0%
0.00%
Q1 2019$89,000
-32.1%
800
-38.5%
0.00%
-100.0%
Q4 2018$131,000
+4.0%
1,300
+30.0%
0.00%0.0%
Q3 2018$126,000
-98.0%
1,000
-97.5%
0.00%
-96.3%
Q4 2014$6,240,000
+2263.6%
40,000
+4900.0%
0.03%
+2600.0%
Q1 2014$264,000
+58.1%
800
-67.0%
0.00%0.0%
Q3 2013$167,000
+53.2%
2,4220.0%0.00%
Q2 2013$109,0002,4220.00%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Sarissa Capital Management LP 635,300$53,308,00010.69%
Senvest Management, LLC 976,127$81,907,0005.65%
Melqart Asset Management (UK) Ltd 390,600$32,775,0002.80%
Asymmetry Capital Management, L.P. 25,918$2,175,0002.14%
Elk Creek Partners, LLC 386,397$32,423,0001.78%
BB BIOTECH AG 545,719$45,791,0001.32%
ALTRINSIC GLOBAL ADVISORS LLC 383,166$32,151,0001.27%
DLD Asset Management, LP 129,000$10,824,0000.82%
Opus Point Partners Management, LLC 3,998$335,0000.73%
Virtus ETF Advisers LLC 8,970$753,0000.67%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders